AstraZeneca Aktie
123,85
EUR
-2,40
EUR
-1,90
%
1.423,00
SEK
-24,00
SEK
-1,66
%
AstraZeneca Aktie Analyse
| 26.10.20 | AstraZeneca Sell | UBS AG | |
| 19.10.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 13.10.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 08.10.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.09.20 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 18.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 10.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 09.09.20 | AstraZeneca Sell | UBS AG | |
| 09.09.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.09.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.09.20 | AstraZeneca overweight | Barclays Capital | |
| 08.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.08.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 31.07.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.07.20 | AstraZeneca overweight | Barclays Capital | |
| 28.07.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 27.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.07.20 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 21.07.20 | AstraZeneca Sell | UBS AG | |
| 21.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.06.20 | AstraZeneca Reduce | Oddo BHF | |
| 19.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.06.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 08.06.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 08.06.20 | AstraZeneca Sell | UBS AG | |
| 08.06.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 04.06.20 | AstraZeneca Sell | UBS AG | |
| 02.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.05.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.05.20 | AstraZeneca Sell | UBS AG | |
| 25.05.20 | AstraZeneca Sell | UBS AG | |
| 22.05.20 | AstraZeneca Sell | UBS AG | |
| 20.05.20 | AstraZeneca overweight | Barclays Capital | |
| 15.05.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.05.20 | AstraZeneca overweight | Barclays Capital | |
| 01.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.04.20 | AstraZeneca Outperform | Credit Suisse Group | |